Illumina Inc. (ILMN)
74.58
-0.48 (-0.64%)
At close: Apr 15, 2025, 3:59 PM
74.50
-0.11%
After-hours: Apr 15, 2025, 06:58 PM EDT
Illumina Revenue Breakdown
| Period Ending | Sep 29, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Jan 1, 2023 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Jan 2, 2022 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Jul 1, 2018 | Apr 1, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Microarray Revenue | 85M | 97M | 98M | 90M | 93M | 111M | 102M | 100M | 97M | 114M | 105M | 93M | 105M | 114M | 86M | 67M | 99M | 102M | 110M | 147M | 140M | 152M |
| Microarray Revenue Growth | -12.37% | -1.02% | +8.89% | -3.23% | -16.22% | +8.82% | +2.00% | +3.09% | -14.91% | +8.57% | +12.90% | -11.43% | -7.89% | +32.56% | +28.36% | -32.32% | -2.94% | -7.27% | -25.17% | +5.00% | -7.89% | n/a |
| Sequencing Revenue | 995M | 979M | 1.02B | 1.03B | 1.08B | 976M | 982M | 1.01B | 1.06B | 1.11B | 1.09B | 1.01B | 1.02B | 979M | 708M | 566M | 760M | 805M | 728M | 699M | 690M | 630M |
| Sequencing Revenue Growth | +1.63% | -4.39% | -0.49% | -4.99% | +10.96% | -0.61% | -3.25% | -4.69% | -3.97% | +1.37% | +7.78% | -0.59% | +4.29% | +38.28% | +25.09% | -25.53% | -5.59% | +10.58% | +4.15% | +1.30% | +9.52% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Jan 1, 2023 | Jan 2, 2022 | Jan 3, 2021 | Dec 29, 2019 | Dec 30, 2018 | Dec 31, 2017 | Jan 1, 2017 | Jan 3, 2016 | Dec 28, 2014 | Dec 29, 2013 | Dec 30, 2012 | Jan 1, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas Revenue | 2.52B | 2.48B | 2.36B | 1.74B | 1.97B | 1.86B | 514M | 456.38M | 379.57M | 342.7M | 276.44M | 568.44M | 528.72M |
| Americas Revenue Growth | +1.69% | +5.13% | +35.21% | -11.47% | +5.69% | +262.65% | +12.63% | +20.23% | +10.76% | +23.97% | -51.37% | +7.51% | n/a |
| Asia Pacific Revenue | 459M | 418M | 377M | 267M | 268M | 618M | 632M | 553.22M | 527.41M | 950.7M | 714.66M | n/a | n/a |
| Asia Pacific Revenue Growth | +9.81% | +10.88% | +41.20% | -0.37% | -56.63% | -2.22% | +14.24% | +4.89% | -44.52% | +33.03% | n/a | n/a | n/a |
| China Revenue | 384M | 472M | 502M | 342M | 372M | 851M | 1.51B | 1.29B | 1.21B | n/a | n/a | n/a | n/a |
| China Revenue Growth | -18.64% | -5.98% | +46.78% | -8.06% | -56.29% | -43.68% | +16.75% | +7.19% | n/a | n/a | n/a | n/a | n/a |
| Emea Revenue | 1.14B | 1.22B | 1.29B | 886M | 933M | 1.78B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Emea Revenue Growth | -6.17% | -5.74% | +45.49% | -5.04% | -47.55% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 2.36B | 2.29B | 2.19B | 1.66B | 1.86B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +3.01% | +4.33% | +32.63% | -10.97% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 29, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Jan 1, 2023 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Jan 2, 2022 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 | Jan 3, 2021 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 29, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 30, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Dec 31, 2017 | Oct 1, 2017 | Jul 2, 2017 | Apr 2, 2017 | Jan 1, 2017 | Oct 2, 2016 | Jul 3, 2016 | Apr 3, 2016 | Jan 3, 2016 | Sep 27, 2015 | Jun 28, 2015 | Mar 29, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 279M | 239M | -88M | 388M | 403M | 303M | 450M | 378M | 519M | 146M | 410M | 308M | 426M | 879M | 413M | 374M | 298M | 192M | 177M | 274M | 233M | 189M | 202M | 211M | 217M | 197M | 197M | 183M | 175M | 167M | 169M | 163M | 146.09M | 139.15M | 148.53M | 149.23M | 147.25M | 136.65M | 124.44M | 116.32M |
| Selling, General, and Administrative Revenue Growth | +16.74% | -371.59% | -122.68% | -3.72% | +33.00% | -32.67% | +19.05% | -27.17% | +255.48% | -64.39% | +33.12% | -27.70% | -51.54% | +112.83% | +10.43% | +25.50% | +55.21% | +8.47% | -35.40% | +17.60% | +23.28% | -6.44% | -4.27% | -2.76% | +10.15% | 0.00% | +7.65% | +4.57% | +4.79% | -1.18% | +3.68% | +11.57% | +4.99% | -6.32% | -0.47% | +1.35% | +7.76% | +9.81% | +6.98% | n/a |
| Research and Development Revenue | 256M | 253M | 325M | 338M | 329M | 315M | 358M | 341M | 346M | 325M | 327M | 323M | 350M | 436M | 202M | 197M | 200M | 172M | 155M | 156M | 161M | 151M | 166M | 169M | 176M | 159M | 151M | 137M | 137M | 134M | 130M | 145M | 129.91M | 125.92M | 124.59M | 123.99M | 114.35M | 99.23M | 96.18M | 91.77M |
| Research and Development Revenue Growth | +1.19% | -22.15% | -3.85% | +2.74% | +4.44% | -12.01% | +4.99% | -1.45% | +6.46% | -0.61% | +1.24% | -7.71% | -19.72% | +115.84% | +2.54% | -1.50% | +16.28% | +10.97% | -0.64% | -3.11% | +6.62% | -9.04% | -1.78% | -3.98% | +10.69% | +5.30% | +10.22% | 0.00% | +2.24% | +3.08% | -10.34% | +11.61% | +3.18% | +1.07% | +0.48% | +8.44% | +15.24% | +3.16% | +4.81% | n/a |